The global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Prostate-Specific Membrane Antigen(PSMA) Inhibitor competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Prostate-Specific Membrane Antigen(PSMA) Inhibitors are a class of drugs that target specific antigens on the surface of prostate cancer cells. These inhibitors block the growth and spread of tumor cells by binding to PSMA and are often used in targeted therapy and imaging studies.

The North American market for Prostate-Specific Membrane Antigen(PSMA) Inhibitor is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Prostate-Specific Membrane Antigen(PSMA) Inhibitor is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor include TargetMol, Merck KGaA, DC Chemicals, Biorbyt, MedChemExpress, QYAOBIO, ACROBiosystems Group, Shanghai Apeptide Co, Xi'an Ruixi Biotechnology Co., Ltd., SNDPHARM TSCHNOLOFY, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prostate-Specific Membrane Antigen(PSMA) Inhibitor. The Prostate-Specific Membrane Antigen(PSMA) Inhibitor market size, estimates, and forecasts are provided in terms of shipments (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Prostate-Specific Membrane Antigen(PSMA) Inhibitor manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Report

Report Metric	Details
Report Name	Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market
Segment by Type	Small Molecule Inhibitors Peptide Inhibitors Other
by Application	Scientific Research Pharmaceuticals
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	TargetMol, Merck KGaA, DC Chemicals, Biorbyt, MedChemExpress, QYAOBIO, ACROBiosystems Group, Shanghai Apeptide Co, Xi'an Ruixi Biotechnology Co., Ltd., SNDPHARM TSCHNOLOFY, Hangzhou MolCore BioPharmatech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Prostate-Specific Membrane Antigen(PSMA) Inhibitor manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Prostate-Specific Membrane Antigen(PSMA) Inhibitor production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Prostate-Specific Membrane Antigen(PSMA) Inhibitor consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market report?

Ans: The main players in the Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market are TargetMol, Merck KGaA, DC Chemicals, Biorbyt, MedChemExpress, QYAOBIO, ACROBiosystems Group, Shanghai Apeptide Co, Xi'an Ruixi Biotechnology Co., Ltd., SNDPHARM TSCHNOLOFY, Hangzhou MolCore BioPharmatech

What are the Application segmentation covered in the Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market report?

Ans: The Applications covered in the Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market report are Scientific Research, Pharmaceuticals

What are the Type segmentation covered in the Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market report?

Ans: The Types covered in the Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market report are Small Molecule Inhibitors, Peptide Inhibitors, Other

1 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Overview

1.1 Product Definition

1.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Type

1.2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Small Molecule Inhibitors

1.2.3 Peptide Inhibitors

1.2.4 Other

1.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Application

1.3.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Scientific Research

1.3.3 Pharmaceuticals

1.4 Global Market Growth Prospects

1.4.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Estimates and Forecasts (2021–2032)

1.4.4 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Manufacturers (2021–2026)

2.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, Industry Ranking, 2024 vs 2025

2.4 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, Product Offerings and Applications

2.8 Global Key Manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, Date of Entry into the Industry

2.9 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Competitive Situation and Trends

2.9.1 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production by Region

3.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Region (2021–2032)

3.2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Region (2027–2032)

3.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Volume by Region (2021–2032)

3.4.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Region (2027–2032)

3.5 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Price Analysis by Region (2021–2026)

3.6 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, and Year-over-Year Growth

3.6.1 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Estimates and Forecasts (2021–2032)

4 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Region

4.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Region (2021–2032)

4.2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Region (2021–2026)

4.2.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production by Type (2021–2032)

5.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production by Type (2021–2026)

5.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production by Type (2027–2032)

5.1.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Type (2021–2032)

5.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Type (2021–2032)

5.2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Type (2021–2026)

5.2.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Type (2027–2032)

5.2.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share by Type (2021–2032)

5.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price by Type (2021–2032)

6 Segment by Application

6.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production by Application (2021–2032)

6.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production by Application (2021–2026)

6.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production by Application (2027–2032)

6.1.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Application (2021–2032)

6.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Application (2021–2032)

6.2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Application (2021–2026)

6.2.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Application (2027–2032)

6.2.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share by Application (2021–2032)

6.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price by Application (2021–2032)

7 Key Companies Profiled

7.1 TargetMol

7.1.1 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.1.2 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.1.3 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 TargetMol Main Business and Markets Served

7.1.5 TargetMol Recent Developments/Updates

7.2 Merck KGaA

7.2.1 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.2.2 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.2.3 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 Merck KGaA Main Business and Markets Served

7.2.5 Merck KGaA Recent Developments/Updates

7.3 DC Chemicals

7.3.1 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.3.2 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.3.3 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 DC Chemicals Main Business and Markets Served

7.3.5 DC Chemicals Recent Developments/Updates

7.4 Biorbyt

7.4.1 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.4.2 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.4.3 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Biorbyt Main Business and Markets Served

7.4.5 Biorbyt Recent Developments/Updates

7.5 MedChemExpress

7.5.1 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.5.2 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.5.3 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 MedChemExpress Main Business and Markets Served

7.5.5 MedChemExpress Recent Developments/Updates

7.6 QYAOBIO

7.6.1 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.6.2 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.6.3 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 QYAOBIO Main Business and Markets Served

7.6.5 QYAOBIO Recent Developments/Updates

7.7 ACROBiosystems Group

7.7.1 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.7.2 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.7.3 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 ACROBiosystems Group Main Business and Markets Served

7.7.5 ACROBiosystems Group Recent Developments/Updates

7.8 Shanghai Apeptide Co

7.8.1 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.8.2 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.8.3 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 Shanghai Apeptide Co Main Business and Markets Served

7.8.5 Shanghai Apeptide Co Recent Developments/Updates

7.9 Xi'an Ruixi Biotechnology Co., Ltd.

7.9.1 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.9.2 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.9.3 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.9.4 Xi'an Ruixi Biotechnology Co., Ltd. Main Business and Markets Served

7.9.5 Xi'an Ruixi Biotechnology Co., Ltd. Recent Developments/Updates

7.10 SNDPHARM TSCHNOLOFY

7.10.1 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.10.2 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.10.3 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.10.4 SNDPHARM TSCHNOLOFY Main Business and Markets Served

7.10.5 SNDPHARM TSCHNOLOFY Recent Developments/Updates

7.11 Hangzhou MolCore BioPharmatech

7.11.1 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

7.11.2 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolio

7.11.3 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production, Value, Price, and Gross Margin (2021–2026)

7.11.4 Hangzhou MolCore BioPharmatech Main Business and Markets Served

7.11.5 Hangzhou MolCore BioPharmatech Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Industry Chain Analysis

8.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Modes and Processes

8.4 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales and Marketing

8.4.1 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Channels

8.4.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Distributors

8.5 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Customer Analysis

9 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Dynamics

9.1 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Industry Trends

9.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Drivers

9.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Challenges

9.4 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Xi'an Ruixi Biotechnology Co., Ltd.

Hangzhou MolCore BioPharmatech

SNDPHARM TSCHNOLOFY

List of Tables

Table 1. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Capacity (kg) by Manufacturers in 2025

Table 4. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production by Manufacturers (kg), 2021–2026

Table 5. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Manufacturers (2021–2026)

Table 6. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value, 2025

Table 10. Global Market Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Manufacturers (US$/g), 2021–2026

Table 11. Global Key Manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, Product Offerings and Applications

Table 13. Global Key Manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, Date of Entry into the Industry

Table 14. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share by Region (2021–2026)

Table 19. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)

Table 22. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg) by Region (2021–2026)

Table 23. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Region (2021–2026)

Table 24. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg) Forecast by Region (2027–2032)

Table 25. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share Forecast by Region (2027–2032)

Table 26. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Average Price (US$/g) by Region (2021–2026)

Table 27. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Average Price (US$/g) by Region (2027–2032)

Table 28. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)

Table 29. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Region (kg), 2021–2026

Table 30. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Market Share by Region (2021–2026)

Table 31. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Forecasted Consumption by Region (kg), 2027–2032

Table 32. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)

Table 34. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Country (kg), 2021–2026

Table 35. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Country (kg), 2027–2032

Table 36. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)

Table 37. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Country (kg), 2021–2026

Table 38. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Country (kg), 2027–2032

Table 39. Asia Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)

Table 40. Asia Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Region (kg), 2021–2026

Table 41. Asia Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Region (kg), 2027–2032

Table 42. Latin America, Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)

Table 43. Latin America, Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Country (kg), 2021–2026

Table 44. Latin America, Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Country (kg), 2027–2032

Table 45. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg) by Type (2021–2026)

Table 46. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg) by Type (2027–2032)

Table 47. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Type (2021–2026)

Table 48. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Type (2027–2032)

Table 49. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share by Type (2021–2026)

Table 52. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share by Type (2027–2032)

Table 53. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price (US$/g) by Type (2021–2026)

Table 54. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price (US$/g) by Type (2027–2032)

Table 55. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg) by Application (2021–2026)

Table 56. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg) by Application (2027–2032)

Table 57. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Application (2021–2026)

Table 58. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Application (2027–2032)

Table 59. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share by Application (2021–2026)

Table 62. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share by Application (2027–2032)

Table 63. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price (US$/g) by Application (2021–2026)

Table 64. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price (US$/g) by Application (2027–2032)

Table 65. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 66. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 67. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 68. TargetMol Main Business and Markets Served

Table 69. TargetMol Recent Developments/Updates

Table 70. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 71. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 72. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 73. Merck KGaA Main Business and Markets Served

Table 74. Merck KGaA Recent Developments/Updates

Table 75. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 76. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 77. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 78. DC Chemicals Main Business and Markets Served

Table 79. DC Chemicals Recent Developments/Updates

Table 80. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 81. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 82. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 83. Biorbyt Main Business and Markets Served

Table 84. Biorbyt Recent Developments/Updates

Table 85. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 86. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 87. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 88. MedChemExpress Main Business and Markets Served

Table 89. MedChemExpress Recent Developments/Updates

Table 90. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 91. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 92. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 93. QYAOBIO Main Business and Markets Served

Table 94. QYAOBIO Recent Developments/Updates

Table 95. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 96. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 97. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 98. ACROBiosystems Group Main Business and Markets Served

Table 99. ACROBiosystems Group Recent Developments/Updates

Table 100. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 101. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 102. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 103. Shanghai Apeptide Co Main Business and Markets Served

Table 104. Shanghai Apeptide Co Recent Developments/Updates

Table 105. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 106. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 107. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 108. Xi'an Ruixi Biotechnology Co., Ltd. Main Business and Markets Served

Table 109. Xi'an Ruixi Biotechnology Co., Ltd. Recent Developments/Updates

Table 110. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 111. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 112. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 113. SNDPHARM TSCHNOLOFY Main Business and Markets Served

Table 114. SNDPHARM TSCHNOLOFY Recent Developments/Updates

Table 115. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Company Information

Table 116. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Specification and Application

Table 117. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 118. Hangzhou MolCore BioPharmatech Main Business and Markets Served

Table 119. Hangzhou MolCore BioPharmatech Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Distributors List

Table 123. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Customers List

Table 124. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Trends

Table 125. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Drivers

Table 126. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Challenges

Table 127. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Prostate-Specific Membrane Antigen(PSMA) Inhibitor

Figure 2. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Share by Type: 2025 vs 2032

Figure 4. Small Molecule Inhibitors Product Picture

Figure 5. Peptide Inhibitors Product Picture

Figure 6. Other Product Picture

Figure 7. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Value by Application (US$ Million), 2021–2032

Figure 8. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Share by Application: 2025 vs 2032

Figure 9. Scientific Research

Figure 10. Pharmaceuticals

Figure 11. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million), 2021–2032

Figure 13. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Capacity (kg), 2021–2032

Figure 14. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production (kg), 2021–2032

Figure 15. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price (US$/g), 2021–2032

Figure 16. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Report Years Considered

Figure 17. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Share by Manufacturers in 2025

Figure 18. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Share by Manufacturers (2025)

Figure 19. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Top 5 and Top 10 Global Players: Market Share by Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue in 2025

Figure 21. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 22. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 23. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)

Figure 24. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 25. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) Growth Rate (2021–2032)

Figure 26. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) Growth Rate (2021–2032)

Figure 27. China Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. Japan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Value (US$ Million) Growth Rate (2021–2032)

Figure 29. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption by Region: 2021 vs 2025 vs 2032 (kg)

Figure 30. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 31. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 32. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Market Share by Country (2021–2032)

Figure 33. U.S. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 34. Canada Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 35. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 36. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Market Share by Country (2021–2032)

Figure 37. Germany Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 38. France Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 39. U.K. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 40. Italy Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 41. Russia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 42. Asia Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 43. Asia Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Market Share by Region (2021–2032)

Figure 44. China Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 45. Japan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 46. South Korea Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 47. China Taiwan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 48. Southeast Asia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 49. India Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 50. Latin America, Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 51. Latin America, Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Market Share by Country (2021–2032)

Figure 52. Mexico Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 53. Brazil Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 54. Turkey Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 55. GCC Countries Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption and Growth Rate (kg), 2021–2032

Figure 56. Global Production Market Share of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Type (2021–2032)

Figure 57. Global Production Value Market Share of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Type (2021–2032)

Figure 58. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price (US$/g) by Type (2021–2032)

Figure 59. Global Production Market Share of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Application (2021–2032)

Figure 60. Global Production Value Market Share of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Application (2021–2032)

Figure 61. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price (US$/g) by Application (2021–2032)

Figure 62. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions